3 Reasons Clover Health Is a Growth Stock That Could Make You Richer Over the Long Term

Sometimes a company can stumble in the quarters after it comes public only to right the ship in the years ahead. Facebook fell 54% after its initial public offering (IPO) and has risen 2,000% in the nine years since. That could be what's happening with Clover Health (NASDAQ: CLOV) -- the company brought to the market through a Chamath Palihapitiya special-purpose acquisition company in January of this year. 

The stock has been more than cut in half since its first day of trading and has endured two public stumbles -- first, when a short-selling firm uncovered a Department of Justice investigation the company hadn't disclosed; and second, after its first earnings release contradicted a pre-IPO claim Palihapitiya made. Still, management appears to be making progress on several fronts that will drive business performance in the years ahead. Here are three reasons that could be good news for shareholders over the long term.

Image source: Getty Images.

Continue reading

Source Fool.com